Inhibition of TGF-β1 might be a novel therapeutic target in the treatment of cardiac fibrosis

被引：4
|
作者：
Wang, Wei [1 ]
Wang, Chunsong [1 ]
Li, Lin [1 ]
Sun, Peng [2 ]
机构：
[1] Taishan Med Univ, Liaocheng Peoples Hosp & Clin Sch, Dept Cardiol, Liaocheng 252000, Peoples R China
[2] Taishan Med Univ, Liaocheng Peoples Hosp & Clin Sch, Dept VIP, Liaocheng 252000, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2018年 / 256卷
关键词：
PATHWAY;
D O I：
10.1016/j.ijcard.2017.08.021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [21] Blockade of KCa3.1: A novel target to treat TGF-β1 induced conjunctival fibrosis
    Anumanthan, Govindaraj
    Wilson, Philip J.
    Tripathi, Ratnakar
    Hesemann, Nathan P.
    Mohan, Rajiv R.
    EXPERIMENTAL EYE RESEARCH, 2018, 167 : 140 - 144
  • [22] Pai-1 Regulates Cardiac Tgf-β Expression And Fibrosis
    Flevaris, Panagiotis
    Eren, Mesut
    Mackie, Alexander
    Khan, Sadiya
    Vaughan, Douglas
    CIRCULATION, 2016, 134
  • [23] Negative regulators of TGF-β1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities
    Gifford, Cody C.
    Tang, Jiaqi
    Costello, Angelica
    Khakoo, Nidah S.
    Nguyen, Tri Q.
    Goldschmeding, Roel
    Higgins, Paul J.
    Samarakoon, Rohan
    CLINICAL SCIENCE, 2021, 135 (02) : 275 - 303
  • [24] TGF-β1 as a therapeutic target in high risk endometrial carcinomas
    Muinelo-Romay, L.
    Colas, E.
    Gil-Moreno, A.
    Barbazan, J.
    Alonso-Alconada, L.
    Curiel, T.
    Cuevas, J.
    Reventos, J.
    Lopez-Lopez, R.
    Abal, M.
    EJC SUPPLEMENTS, 2010, 8 (07): : 55 - 56
  • [25] Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis
    Siapoush, Samaneh
    Rezaei, Ramazan
    Alavifard, Helia
    Hatami, Behzad
    Zali, Mohammad Reza
    Vosough, Massoud
    Lorzadeh, Shahrokh
    Los, Marek J.
    Baghaei, Kaveh
    Ghavami, Saeid
    LIFE SCIENCES, 2023, 329
  • [26] Cardiac Remodeling in Systemic Sclerosis: TGF-β/Fra2-Dependent Autophagy As a Novel Target for Heart Fibrosis
    Stellato, Mara
    Rudnik, Michal
    Renoux, Florian
    Pachera, Elena
    Sotlar, Karl
    Klingel, Karin
    Henes, Joerg C.
    Blyszczuk, Przemyslaw
    Distler, Oliver
    Kania, Gabriela
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [27] LncRNA ZFAS1 might be a novel therapeutic target in the treatment of cardiovascular disease
    Wang, Mengzan
    Xie, Hong
    Dai, Bo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 337 : 99 - 99
  • [28] Melatonin serves as a novel treatment in bladder fibrosis through TGF-β1/Smad and EMT
    Zhang, Yang
    Gong, Sun
    He, Weixin
    Yuan, Jie
    Dong, Di
    Zhang, Jialong
    Wang, Haomin
    Chen, Binghai
    PLOS ONE, 2024, 19 (03):
  • [29] Inhibition of IL-17 might be a novel therapeutic target in the treatment of myocardial ischemia reperfusion injury
    Su, Jing-Li
    Jiao, Yue-Ru
    Li, Tai
    Yao, Heng-Chen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 239 : 29 - 29
  • [30] Transforming growth factor (TGF)-β1 signal pathway: A promising therapeutic target for attenuating cardiac fibrosis
    Xie, Jin
    Tu, Tao
    Zhou, Shenghua
    Liu, Qiming
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 239 : 9 - 9
12345